VCAM1 and cancer: Thus, designing a nano-system to co-deliver the VCAM-1 inhibitor Suc and the chemotherapeutic Dox might simultaneously eliminate primary tumors and their metastases, which will be greatly beneficial for the treatment of metastatic malignant tumors.